Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)
Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –
Liquidia total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Liquidia's total debt was $19.88M at Dec 31, 2022. For fiscal 2022 it was $19.88M, up 91.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $19.88M | +91.0% |
| FY2021 | Dec 31, 2021 | $10.41M | +1.1% |
| FY2020 | Dec 31, 2020 | $10.29M | -35.2% |
| FY2019 | Dec 31, 2019 | $15.88M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $19.88M | +91.0% |
| Q3 FY2022 | Sep 30, 2022 | $19.74M | +91.1% |
| Q2 FY2022 | Jun 30, 2022 | $19.61M | +91.2% |
| Q1 FY2022 | Mar 31, 2022 | $19.48M | +91.4% |
| Q4 FY2021 | Dec 31, 2021 | $10.41M | +1.1% |
| Q3 FY2021 | Sep 30, 2021 | $10.33M | -34.9% |
| Q2 FY2021 | Jun 30, 2021 | $10.25M | – |
| Q1 FY2021 | Mar 31, 2021 | $10.18M | – |
| Q4 FY2020 | Dec 31, 2020 | $10.29M | – |
| Q4 FY2019 | Dec 31, 2019 | $15.88M | – |
See a number that looks wrong?